Samar R El Khoudary1, Xirun Chen1, Alexis Nasr1, Kelly Shields2, Emma Barinas-Mitchell1, Imke Janssen3, Susan A Everson-Rose4, Lynda Powell4, Karen Matthews5. 1. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania. 2. Enterprise Analytics, Highmark Health, Pittsburgh, Pennsylvania. 3. Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois. 4. Department of Medicine and Program in Health Disparities Research, University of Minnesota, Minneapolis. 5. Department of Psychiatry, University of Pittsburgh School of Medicine, Pennsylvania.
Abstract
BACKGROUND: Higher perivascular adipose tissue (PVAT) contributes to adverse physiologic alterations in the vascular wall, and thus could potentially limit normal physical function later in life. We hypothesize that higher PVAT volume at midlife is prospectively associated with slower gait speed later in life, independent of overall adiposity and other risk factors. METHODS: Participants from the Study of Women's Health Across the Nation (SWAN) cardiovascular fat ancillary study were included. PVAT volume around the descending aorta was quantified using existing computed tomography scans at midlife, while gait speed was measured after an average of 10.4 ± 0.7 years. RESULTS: Two hundred and seventy-six women (aged 51.3 ± 2.8 years at PVAT assessment) were included. Mean gait speed was 0.96 ± 0.21 m/s. Adjusting for study site, race, education level, menopausal status, and length of descending aorta at PVAT assessment, and age, body mass index, difficulty paying for basics, overall health and smoking status at gait speed assessment, a higher midlife PVAT volume was associated with a slower gait speed later in life (p = .03). With further adjustment for presence of any comorbid conditions by the time of gait speed assessment, the association persisted; every 1SD increase in log-PVAT was associated with 3.3% slower gait speed (95% confidence interval: 0.3-6.3%; p = .03). CONCLUSION: Greater PVAT in midlife women may contribute to poorer physical function in older age supporting a potential role of midlife PVAT in multiple domains of healthy aging. Additional research is needed to fully elucidate the physiologic changes associated with PVAT that may underlie the observed associations.
BACKGROUND: Higher perivascular adipose tissue (PVAT) contributes to adverse physiologic alterations in the vascular wall, and thus could potentially limit normal physical function later in life. We hypothesize that higher PVAT volume at midlife is prospectively associated with slower gait speed later in life, independent of overall adiposity and other risk factors. METHODS:Participants from the Study of Women's Health Across the Nation (SWAN) cardiovascular fat ancillary study were included. PVAT volume around the descending aorta was quantified using existing computed tomography scans at midlife, while gait speed was measured after an average of 10.4 ± 0.7 years. RESULTS: Two hundred and seventy-six women (aged 51.3 ± 2.8 years at PVAT assessment) were included. Mean gait speed was 0.96 ± 0.21 m/s. Adjusting for study site, race, education level, menopausal status, and length of descending aorta at PVAT assessment, and age, body mass index, difficulty paying for basics, overall health and smoking status at gait speed assessment, a higher midlife PVAT volume was associated with a slower gait speed later in life (p = .03). With further adjustment for presence of any comorbid conditions by the time of gait speed assessment, the association persisted; every 1SD increase in log-PVAT was associated with 3.3% slower gait speed (95% confidence interval: 0.3-6.3%; p = .03). CONCLUSION: Greater PVAT in midlife women may contribute to poorer physical function in older age supporting a potential role of midlife PVAT in multiple domains of healthy aging. Additional research is needed to fully elucidate the physiologic changes associated with PVAT that may underlie the observed associations.
Authors: E Okamoto; T Couse; H De Leon; J Vinten-Johansen; R B Goodman; N A Scott; J N Wilcox Journal: Circulation Date: 2001-10-30 Impact factor: 29.690
Authors: Samar R El Khoudary; Kelly J Shields; Imke Janssen; Carrie Hanley; Matthew J Budoff; Emma Barinas-Mitchell; Susan A Everson-Rose; Lynda H Powell; Karen A Matthews Journal: J Clin Endocrinol Metab Date: 2015-07-15 Impact factor: 5.958
Authors: Daniel K White; Tuhina Neogi; Michael C Nevitt; Christine E Peloquin; Yanyan Zhu; Robert M Boudreau; Jane A Cauley; Luigi Ferrucci; Tamara B Harris; Susan M Satterfield; Eleanor M Simonsick; Elsa S Strotmeyer; Yuqing Zhang Journal: J Gerontol A Biol Sci Med Sci Date: 2012-10-09 Impact factor: 6.053
Authors: Candace K McClure; Samar R El Khoudary; Carrie A Karvonen-Gutierrez; Kelly R Ylitalo; Kristin Tomey; Trang VoPham; Barbara Sternfeld; Jane A Cauley; Siobán Harlow Journal: Exp Gerontol Date: 2013-11-07 Impact factor: 4.032
Authors: Mary M McDermott; Lu Tian; Luigi Ferrucci; Kiang Liu; Jack M Guralnik; Yihua Liao; William H Pearce; Michael H Criqui Journal: J Am Geriatr Soc Date: 2008-02-13 Impact factor: 5.562
Authors: Tapan K Chatterjee; Lynn L Stoll; Gerene M Denning; Allan Harrelson; Andra L Blomkalns; Gila Idelman; Florence G Rothenberg; Bonnie Neltner; Sara A Romig-Martin; Eric W Dickson; Steven Rudich; Neal L Weintraub Journal: Circ Res Date: 2009-01-02 Impact factor: 17.367
Authors: Carrie Hanley; Karen A Matthews; Maria M Brooks; Imke Janssen; Matthew J Budoff; Akira Sekikawa; Suresh Mulukutla; Samar R El Khoudary Journal: Menopause Date: 2018-01 Impact factor: 2.953
Authors: Jenna M Napoleone; Robert M Boudreau; Brittney S Lange-Maia; Samar R El Khoudary; Kelly R Ylitalo; Andrea M Kriska; Carrie A Karvonen-Gutierrez; Elsa S Strotmeyer Journal: J Gerontol A Biol Sci Med Sci Date: 2022-02-03 Impact factor: 6.591